Skip to main content

Antidepressant Use Tied to Reduced Genital Sensitivity

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 19, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, Dec. 19, 2024 -- Antidepressants may reduce genital sensitivity when compared with other medications, according to a study recently published in Social Psychiatry and Psychiatric Epidemiology.

Yassie Pirani, M.S.W., from the Canadian Post-SSRI/SNRI Sexual Dysfunction Society in Vancouver, British Columbia, and colleagues estimated the frequency of persistent posttreatment genital hypoesthesia (PPTGH) among past users of psychiatric treatments. The analysis included data from participants in UnACoRN, a survey of sexual and gender minority youth (aged 15 to 29 years) with a history of psychiatric drug use.

The researchers found that 574 of 2,179 survey participants reported genital hypoesthesia. Respondents were older and more likely to report male sex assignment at birth, history of hormonal therapy, and history of psychiatric drug use. Among antidepressant users, the frequency of PPTGH was 13.2 versus 0.9 percent among users of other medications (adjusted odds ratio, 14.2).

"Antidepressant discontinuation is strongly associated with PPTGH in the United States and Canada where selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitor medications account for 80 percent of antidepressant prescriptions," the authors write. “We call for standardized international warnings and transparent, informed consent.”

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted December 2024

Read this next

Psilocybin Plus Psychotherapy Offers Lasting Benefit in Cancer, Depression

MONDAY, June 16, 2025 -- For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief for...

Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases

THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...

Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors

THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.